99311: Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation among Cancer Survivors (1 credit)

 The accrual goal for this study was reached on November 6, 2013. 

Appendices •   Archived Amendments  •  Adverse Events   

 

Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275

E-mail
resbase@wakehealth.edu

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 11-07-2013
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.